[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-CSN-030926148--":3,"related-articles-undefined-undefined-3b0c143a-1ddd-4edc-8eae-c9192ac88aac-true":15},{"id":4,"type":5,"title":6,"pubDate":7,"logoUrl":8,"anpFeedCategory":9,"organisationTitle":10,"thirdParty":11,"body":12,"orgId":13,"description":14},"CSN-030926148","PRESSRELEASE"," Resonant Clinical Solutions Expands Advanced-Therapy and Cryogenic Storage Capabilities with Acquisition of Creapharm Bioservices","2026-09-03T15:30:27.000+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Fimg\u002Fpr-newswire.png","Economie","PR Newswire",true,"\u003Cp> LEESBURG, Va., Sept. 3, 2026 \u002FPRNewswire\u002F -- Resonant Clinical Solutions, a global clinical solutions partner serving life sciences organizations across the clinical supply chain and sample lifecycle, today announced that it has acquired France-based Creapharm Bioservices from Myonex, a global clinical trial supply and packaging company with operations in the U.S., France, and Germany. The acquisition expands Resonant's Biorepository capabilities in Europe and strengthens its ability to support increasingly complex clinical programs, including cell and gene therapy trials requiring highly specialized handling and storage.\u003C\u002Fp>\u003Cp> Based in Bailly-Romainvilliers, France, Creapharm Bioservices provides specialized biobanking and cryogenic storage for biotherapeutics, Advanced Therapy Medicinal Products (ATMPs) and biological samples, including vapor-phase nitrogen storage to -196°C, mechanical freezer and cold storage, Good Manufacturing Practice (GMP) sample storage and Good Distribution Practice (GDP) quality-control sample custody. The acquisition addresses a growing need as clinical pipelines shift toward increasingly specialized modalities. A  published by IQVIA in August 2025 found that non-small-molecule assets, including advanced modalities, accounted for 46% of Phase I–III clinical trial starts in 2024, up from 38% five years earlier.\u003C\u002Fp>\u003Cp> \"Life sciences companies increasingly need partners with the specialized expertise, infrastructure, and global reach to support more of the clinical trial lifecycle,\" said Christophe Berthoux, Chief Executive Officer, Resonant Clinical Solutions. \"Creapharm Bioservices strengthens our ability to support customers developing complex and sensitive therapies, including cell and gene therapies, while complementing our existing offerings across Biorepository, Kitting, and Equipment & Ancillary services. Together, these capabilities advance our strategy to support more of the clinical journey at global scale.\"\u003C\u002Fp>\u003Cp> Creapharm Bioservices is now part of Resonant's Biorepository business, expanding its global footprint and adding specialized expertise in cryogenic storage and the handling of highly sensitive biological materials. Creapharm Bioservices adds complementary capabilities including:\u003C\u002Fp>\u003Cp> \"Creapharm Bioservices strengthens the specialized support we can provide customers that are managing increasingly sensitive materials and complex clinical programs,\" said Corey Stone, Vice President and General Manager - Biorepository, Resonant Clinical Solutions. \"We are excited to welcome the Creapharm Bioservices team and build on the strong technical knowledge and customer relationships they have established.\"\u003C\u002Fp>\u003Cp> \"Creapharm Bioservices is a natural fit for Resonant,\" said Greg Lavin, Chief Executive Officer of Myonex. \"Its specialized expertise is a strong complement to Resonant's global Biorepository offering. This transaction allows Myonex to further concentrate on our core strengths and future strategy, and we look forward to seeing the Creapharm Bioservices team achieve continued success under Resonant's leadership.\"\u003C\u002Fp>\u003Cp> Financial terms of the transaction were not disclosed.\u003C\u002Fp>\u003Cp> Resonant Clinical Solutions is a global clinical solutions partner serving life sciences organizations across the clinical supply chain and sample lifecycle. Through its Biorepository, Kitting, and Equipment & Ancillary businesses, Resonant helps customers manage complexity, reduce risk, and support critical clinical programs around the world. With more than 850 employees across the U.S., U.K., and Europe, Resonant has supported more than 2,500 clinical trials, facilitated more than 20,000 customer-site shipments, and manages more than 100 million research assets in storage. The company serves pharmaceutical and biotechnology companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and diagnostic and reference laboratories.\u003C\u002Fp>\u003Cp> Resonant's mission is to empower its partners with comprehensive, global clinical supply chain and sample lifecycle solutions that remove complexity and enable them to focus on science and patients. For more information, visit\u003C\u002Fp>\u003Cp> View original content to download multimedia: https:\u002F\u002Fwww.prnewswire.co.uk\u002Fnews-releases\u002Fresonant-clinical-solutions-expands-advanced-therapy-and-cryogenic-storage-capabilities-with-acquisition-of-creapharm-bioservices-302868200.html\u003C\u002Fp>","3b0c143a-1ddd-4edc-8eae-c9192ac88aac","LEESBURG, Va., Sept. 3, 2026 \u002FPRNewswire\u002F -- Resonant Clinical Solutions, a global clinical solutions partner serving life sciences organizations across the cli",[16,21,26,31,36,41,46,51,55,60],{"id":17,"title":18,"pubDate":19,"logoUrl":8,"thirdParty":11,"orgId":13,"description":20},"CSN-231026126"," Qatar's Years of Culture Initiative Announces Partner Countries Through 2030","2026-10-23T18:52:24.000+02:00","Italy, the Netherlands, Switzerland, Portugal and Spain named future Years of Culture partners DOHA, Qatar, Oct. 23, 2026 \u002FPRNewswire\u002F -- The Years of Culture i",{"id":22,"title":23,"pubDate":24,"logoUrl":8,"thirdParty":11,"orgId":13,"description":25},"CSN-231026122"," Sungrow Shares Perspectives on Europe's Energy Transition at BloombergNEF London Summit","2026-10-23T18:03:24.000+02:00","LONDON, Oct. 23, 2026 \u002FPRNewswire\u002F -- As Europe experiences growing energy transition demands with deeper electrification and smarter grid integration emerging ",{"id":27,"title":28,"pubDate":29,"logoUrl":8,"thirdParty":11,"orgId":13,"description":30},"CSN-231026109"," THE POWER OF WILL: A SERIES OF CONVERSATIONS ABOUT DETERMINATION AND INDIVIDUALITY","2026-10-23T16:38:25.000+02:00","MIAMI, Oct. 23, 2026 \u002FPRNewswire\u002F -- Armani beauty: The Power of WILL is a video interview series hosted by artist and digital storyteller Devon Rodriguez. Comb",{"id":32,"title":33,"pubDate":34,"logoUrl":8,"thirdParty":11,"orgId":13,"description":35},"CSN-231026103"," Lassa introduces new winter tyre Wintus 3 for light commercial vehicles","2026-10-23T16:22:25.000+02:00","Lassa, the international tyre brand of Brisa, Türkiye's tyre industry leader, has developed Wintus 3 as a dedicated winter tyre for light commercial vehicle use",{"id":37,"title":38,"pubDate":39,"logoUrl":8,"thirdParty":11,"orgId":13,"description":40},"CSN-231026101"," TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026","2026-10-23T16:03:24.000+02:00","GREATER NOIDA, India, Oct. 23, 2026 \u002FPRNewswire\u002F -- The Renewable Energy India Expo (REI) opened on October 22 at the India Expo Centre in Greater Noida. As one",{"id":42,"title":43,"pubDate":44,"logoUrl":8,"thirdParty":11,"orgId":13,"description":45},"CSN-231026095"," RINA: Paolo Moretti appointed Group Chief Executive Officer","2026-10-23T15:37:24.000+02:00","GENOA, Italy, Oct. 23, 2026 \u002FPRNewswire\u002F -- RINA S.p.A.'s new Board of Directors has appointed Paolo Moretti, currently General Manager, as Group Chief Executiv",{"id":47,"title":48,"pubDate":49,"logoUrl":8,"thirdParty":11,"orgId":13,"description":50},"CSN-231026084"," XbotGo Named World's No. 1 Consumer Team Sports AI Tracking Camera Brand","2026-10-23T15:01:26.000+02:00","XbotGo recognized as the market leader in consumer team sports AI tracking technology based on 2025 unit sales. MOUNTAIN VIEW, Calif., Oct. 23, 2026 \u002FPRNewswire",{"id":52,"title":53,"pubDate":49,"logoUrl":8,"thirdParty":11,"orgId":13,"description":54},"CSN-231026085"," Anycubic and Thingiverse Announce Exclusive Partnership to Expand Access to 3D Models","SHENZHEN, China, Oct. 23, 2026 \u002FPRNewswire\u002F -- Anycubic, a global brand in 3D printing, announced an exclusive partnership with Thingiverse, one of the largest ",{"id":56,"title":57,"pubDate":58,"logoUrl":8,"thirdParty":11,"orgId":13,"description":59},"CSN-231026082"," Infosys:Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues","2026-10-23T14:58:24.000+02:00","- Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth - FY 27 revenue guidance revised to 1%-2% and margin guidan",{"id":61,"title":62,"pubDate":63,"logoUrl":8,"thirdParty":11,"orgId":13,"description":64},"CSN-231026081"," Canadian Molly Carlson Becomes First Woman to Dive off a Free-Standing Iceberg in Newfoundland","2026-10-23T14:52:25.000+02:00","Red Bull athlete Molly Carlson (Canada) completed a backwards dive of approximately 15 metres off Twillingate, Newfoundland, after months of training with ice c"]